Medtronic plc — Director's Dealing 2021

Jul 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-06-28

Reporting Person: Martha Geoffrey (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-28	Ordinary Shares	M	11500	$55.32	Acquired	93448	Direct
2021-06-28	Ordinary Shares	S	11500	$125.29	Disposed	81948	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-28	Stock Option (Right to Buy)	$55.32	M	11500	Disposed	2023-07-29	Ordinary Shares (11500)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment.

F3: This balance increased by 266 shares due to exempt transactions such as dividend reinvestment.

F4: This option to purchase 1,808 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 1,808 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.

F5: This option to purchase 20,481 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 20,481 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.

F6: This amount has been adjusted to correct a mathematical error that occurred in Column 9 in the previously filed Form 4 on April 7, 2021.